Report Detail
(Post-pandemic Era)-Global The Tafenoquine Market Segment Research Report 2021
- RnM4350511 |
- 01 November, 2021 |
- Global |
- 83 Pages |
- XYZResearch |
- Pharma & Healthcare
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global The Tafenoquine market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in The Tafenoquine market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China The Tafenoquine production is XX (K Units). US market value in 2021 is about USD XX billion, and US The Tafenoquine production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe The Tafenoquine production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of The Tafenoquine Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in The Tafenoquine Market?
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
Merck
BOC Sciences
Amadis Chemical Company Limited
Pharmacodia (Beijing) Co.,Ltd
...
Major Type of The Tafenoquine Covered in XYZResearch report:
Powder
Pills
Application Segments Covered in XYZResearch Market
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global The Tafenoquine Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global The Tafenoquine Market by Value
- 2.2.1 Global The Tafenoquine Revenue by Type
- 2.2.2 Global The Tafenoquine Market by Value (%)
- 2.3 Global The Tafenoquine Market by Production
- 2.3.1 Global The Tafenoquine Production by Type
- 2.3.2 Global The Tafenoquine Market by Production (%)
3. The Major Driver of The Tafenoquine Industry
- 3.1 Historical & Forecast Global The Tafenoquine Demand
- 3.2 Largest Application for The Tafenoquine (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional The Tafenoquine Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of The Tafenoquine Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US The Tafenoquine Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe The Tafenoquine Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China The Tafenoquine Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan The Tafenoquine Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India The Tafenoquine Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea The Tafenoquine Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia The Tafenoquine Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global The Tafenoquine Average Price Trend
- 12.1 Market Price for Each Type of The Tafenoquine in US (2017-2021)
- 12.2 Market Price for Each Type of The Tafenoquine in Europe (2017-2021)
- 12.3 Market Price for Each Type of The Tafenoquine in China (2017-2021)
- 12.4 Market Price for Each Type of The Tafenoquine in Japan (2017-2021)
- 12.5 Market Price for Each Type of The Tafenoquine in India (2017-2021)
- 12.6 Market Price for Each Type of The Tafenoquine in Korea (2017-2021)
- 12.7 Market Price for Each Type of The Tafenoquine in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 The Tafenoquine Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of The Tafenoquine
14. The Tafenoquine Competitive Landscape
- 14.1 GlaxoSmithKline Pharmaceuticals (GSK)
- 14.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Profiles
- 14.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Product Introduction
- 14.1.3 GlaxoSmithKline Pharmaceuticals (GSK) The Tafenoquine Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- 14.2.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Profiles
- 14.2.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Product Introduction
- 14.2.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. The Tafenoquine Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 J & K Scientific LTD
- 14.3.1 J & K Scientific LTD Company Profiles
- 14.3.2 J & K Scientific LTD Product Introduction
- 14.3.3 J & K Scientific LTD The Tafenoquine Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Merck
- 14.4.1 Merck Company Profiles
- 14.4.2 Merck Product Introduction
- 14.4.3 Merck The Tafenoquine Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 BOC Sciences
- 14.5.1 BOC Sciences Company Profiles
- 14.5.2 BOC Sciences Product Introduction
- 14.5.3 BOC Sciences The Tafenoquine Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Amadis Chemical Company Limited
- 14.6.1 Amadis Chemical Company Limited Company Profiles
- 14.6.2 Amadis Chemical Company Limited Product Introduction
- 14.6.3 Amadis Chemical Company Limited The Tafenoquine Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 Pharmacodia (Beijing) Co.,Ltd
- 14.7.1 Pharmacodia (Beijing) Co.,Ltd Company Profiles
- 14.7.2 Pharmacodia (Beijing) Co.,Ltd Product Introduction
- 14.7.3 Pharmacodia (Beijing) Co.,Ltd The Tafenoquine Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
15. Conclusion
Summary:
Get latest Market Research Reports on Tafenoquine. Industry analysis & Market Report on Tafenoquine is a syndicated market report, published as (Post-pandemic Era)-Global The Tafenoquine Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Tafenoquine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
